Advertisement
Screener

Tempest Therapeutics, Inc. (TPST) Restricted Cash

2.8 / 5 stars · 68/120 Roast Me

Tempest Therapeutics, Inc. Restricted Cash

Tempest Therapeutics, Inc. (TPST) had Restricted Cash of $789.00 thousand as of 2018-09-30, per its 10-Q filed 2018-11-09.

Discontinued › Balance Sheet › Assets › Restricted Cash and Cash Equivalent

us-gaap:RestrictedCash · last filed 2018-11-09

  • 2018-09-30: Restricted Cash $789.00K.
  • 2018-06-30: Restricted Cash $789.00K.
  • 2018-03-31: Restricted Cash $791.00K.
  • 2017-09-30: Restricted Cash $789.00K.
Period endRestricted Cash
2018-09-30$789.00K
10-Q · filed 2018-11-09
2018-06-30$789.00K
10-Q · filed 2018-08-09
2018-03-31$791.00K
10-Q · filed 2018-05-03
2017-09-30$789.00K
10-Q · filed 2018-11-09
2017-06-30$812.00K
10-Q · filed 2018-08-09
2017-03-31$439.00K
10-Q · filed 2018-05-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
BIOVIE INC. (BIVI)United States$0.012B
MUSTANG BIO, INC. (MBIO)United States$0.013B
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B